JAM
PLSE icon

JW Asset Management’s Pulse Biosciences PLSE Stock Holding History

JW Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-21,954
Closed -$448K – 39
2017
Q1 		$448K Sell
21,954
-15,500
-41% -$211K 0.09% 34
2016
Q4 		$229K Hold
37,454
– – 0.15% 30
2016
Q3 		$236K Buy
+37,454
New +$191K 0.16% 30

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TF
TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JW Asset Management's PLSE Position: Q2 2017 in Review

JW Asset Management sold out of Pulse Biosciences (PLSE) in Q2 2017, closing a stake of 21,954 shares — an estimated $448K sold.

JW Asset Management first reported a position in PLSE in Q3 2016 and held it in 3 quarters. The position peaked at $448K in Q1 2017. 49 funds tracked by Wall St. Rank hold PLSE as of Q2 2017.

  • JW Asset Management reported no remaining Pulse Biosciences position as of Q2 2017 after selling out during the quarter.
  • JW Asset Management sold 21,954 Pulse Biosciences shares in Q2 2017, an estimated $448K.
  • JW Asset Management first reported a position in Pulse Biosciences in Q3 2016 and held it in 3 quarters.
  • JW Asset Management's Pulse Biosciences position peaked at $448K in Q1 2017.
  • 49 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2017.

Based on JW Asset Management's 13F filing for Q2 2017, filed 4 Aug 2017.